SKYTROFA® (lonapegsomatropin) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of paediatric growth hormone deficiency.[1] SINGAPORE, May 29, 2025 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce...
Read More Details
Finally We wish PressBee provided you with enough information of ( NEW THERAPY FOR CHILDREN WITH GROWTH HORMONE DEFICIENCY APPROVED IN AUSTRALIA )
Also on site :
- 'Full House' Star, 43, Makes Rare Comment About Ashley Olsen
- '90s Rapper and Actor, 61, Makes Rare Red Carpet Appearance
- A Gaza-bound aid boat carrying Greta Thunberg and other activists has been diverted to Israel